Bowel preparation is essential for successful colonoscopy examination, and the most important factor is the bowel preparation agent used. However, selection of a bowel preparation agent invariably involves compromise. Originally, bowel preparation was performed for radiologic and surgical purposes, when the process involved dietary limitations, cathartics, and enemas, which had many side effects. Development of polyethylene glycol (PEG) solution led to substantive advancement of bowel preparation; however, despite its effectiveness and safety, the large volume involved, and its salty taste and unpleasant odor reduce compliance. Accordingly, modified PEG solutions requiring consumption of lower volumes and sulfate-free solutions were developed. Aqueous sodium phosphate is more effective and better tolerated than PEG solutions; however, fatal complications have occurred due to water and electrolyte shifts. Therefore, aqueous sodium phosphate was withdrawn by the US Food and Drug Administration, and currently, only sodium phosphate tablets remain available. In addition, oral sulfate solution and sodium picosulfate/magnesium citrate are also available, and various studies have reported on adjunctive preparations, such as hyperosmolar or stimulant laxatives, antiemetics, and prokinetics, which are now in various stages of development. (Korean J Gastroenterol 2014;63:268-275) 
INTRODUCTION
Colonoscopy is considered the optimal and standard method for evaluation of the colon. For successful colonoscopy, a skilled colonoscopist, patient cooperation, and adequate bowel preparation are necessary. Poor bowel preparation reduces the quality of colonoscopy, increases complication risk, reduces polyp detection rates, increases pain by extending insertion times, and increases medical costs.
Thus, adequate bowel preparation is essential for successful colonoscopy and this largely depends on the type of agent used for bowel preparation. An ideal bowel preparation agent would be easily taken, inexpensive, have an excellent cleansing effect, and would not cause fluid or electrolyte shifts.
Here, we review the development of a bowel preparation agent from a historical perspective and describe agents currently being developed (Table 1) .
DEVELOPMENTS IN BOWEL PREPARATION
Colonoscopy preparations evolved from radiologic and surgical preparations. 1 Early mechanical preparation meth- In the 1980s, Davis et al. 4 developed an osmotically balanced, polyethylene glycol-electrolyte lavage solution (PEG solution) that did not cause loss of water or electrolyte or suffer from the risk of gas explosion. The cleansing effectiveness and safety of PEG solution were confirmed by many stud-ies, [5] [6] [7] and it continues to be the preparation method of choice. However, the large volume required, as well as its salty taste, and unpleasant smell reduce compliance, thus, sulfate-free, low-volume PEG solutions were developed.
Sodium phosphate (NaP) solution osmotic agent developed in the 1990s 8 , which had the advantage of a low administered volume versus PEG solution, however, its disadvantages included risks of hyperphosphatemia, hypocalcemia, and hypokalemia in patients with renal failure, congestive heart failure, advanced liver disease, or an aphthous ulcer-like mucosal lesion. Around the same time, another bowel preparation method, pulsed rectal irrigation combined with magnesium citrate was developed. 9 This method involves ingestion of 10 ounces of magnesium citrate the evening before the procedure and a 30-minute infusion of short pulses of warm tap water through a rectal tube immediately before colonoscopy. 10 This regimen showed no significant differences in terms of quality of colonic cleansing versus PEG solution 9 ; however, it required more time and skilled nursing. Nevertheless, it remains a good alternative when a full-volume PEG solution cannot be tolerated.
TYPES OF BOWEL PREPARATION AGENTS
Bowel preparation agents can be classified according to three types.
-PEG solutions, oral gut lavage solutions with high-volumes.
-osmotic agents, such as sodium phosphate, magnesium citrate, lactulose, and mannitol, which draw plasma water into the bowel lumen.
-stimulants, such as caster oil, senna, sodium picosulfate, and bisacodyl, which stimulate the colonic peristalsis.
Polyethylene glycol solutions 1) Overview
Since the original development of an osmotically balanced PEG solution, better solutions have been developed. PEG solutions are more effective and better tolerated than regimens of diet combined with cathartic agents, high-volume balanced electrolyte solutions, or mannitol-based solutions, 10, 11 and the original 4-liter dosing regimen rapidly became the standard bowel preparation method due its characteristics of being rapid, safe, and effective. The primary mechanism responsible for minimizing water and electrolyte shifts involves the inhibition of sodium ion absorption by sulfate ions. Disadvantages of PEG solutions include the large volume required, a salty taste and unpleasant smell, due to the presence of sodium sulfate, and these reduce patient compliance. In practice, approximately 5% to 15% of patients do not complete the preparation. 10, 18, 19 Furthermore, the additional use of enemas does not offer any improvement in the efficacy of PEG solutions, but considerably increases patient discomfort. 20 Divided regimens are superior and better tolerated than the standard 4-liter single dose regimen. 21 In one study, ingestion of PEG solution less than 5 hours before the procedure resulted in better preparation than when administered more than 19 hours beforehand. 22 According to a recent study, the method and/or timing of administration are more important determinants of quality of preparation than dietary restriction, 23 and in another study, walking exercise during bowel preparation was found to improve colonoscopic bowel cleansing without significantly increasing patient discomfort. 24 Addition of 10 mg of oral bisacodyl to PEG was not found to result in significant improvement of colonic cleansing or overall patient tolerance when used as an adjunct with full-volume PEG. 25 However, in another study, in which efficacy and patient tolerance to 4 liters of PEG were 26, 29, 30 In a study on the use of senna, its addition was found to be effective, safe, and well tolerated, like bisacodyl [31] [32] [33] [34] ; however, abdominal pain was reported by some patients administered high-dose senna (24 mg). 35 On the other hand, the addition of prokinetic agents to PEG did not result in improvement of bowel preparation, but reduced nausea and abdominal distress.
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2) Sulfate-free PEG
In an effort to overcome the objectionable smell and taste of standard PEG solutions, sulfate-free and flavored solutions have been developed. 39 These are less salty, more palatable, and comparable to standard solutions in terms of effective colonic cleansing and overall patient tolerance. 2. Sodium phosphate solutions
1) Overview
Aqueous sodium phosphate is a low-volume hyperosmotic solution containing 48 g (400 mmol) of monobasic sodium phosphate and 18 g (130 mmol) of dibasic sodium phosphate per 100 mL. 44 Sodium phosphate, an osmotic agent, draws water from plasma into the bowel lumen, and causes peristalsis and bowel cleansing due to water retention. Thus, the use of sodium phosphate can cause large fluid and electrolyte shifts. In one meta-analysis, sodium phosphate was found to be more effective for bowel cleansing and better tolerated than PEG solution, 45 whereas another found that sodium phosphate solutions were superior to PEG solutions and were better tolerated, but not significantly more effective than PEG. 46 The main reasons for the improved tolerability were a better flavor and a smaller sodium phosphate solution volume. 47, 48 In addition, because of their effectiveness and lower cost, colonoscopists are more likely to consider sodium phosphate solutions more acceptable. 10, 49 However, it should be added that patients with renal failure, liver disease with ascites, or severe heart disease were excluded from most of these studies. Patients with compromised renal function, dehydration, hypercalcemia, hypertension on angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) have experienced phosphate nephropathy after taking oral sodium phosphate solutions. 50 These effects appear to be age-and dose-related. 51 In addition, sodium phosphate solutions have been associated with hypocalcemia, hypokalemia, increased plasma osmolality, hyponatremia, and, conversely, hypernatremia. 38, 52, 53 Rare adverse events, such as nephrocalcinosis with acute renal failure have also been reported, particularly in patients taking ACE inhibitors, ARBs, or diuretics. 53, 54 Renal failure due to hyperphosphatemia (acute phosphate nephropathy) has recently been reported even in patients with normal kidney function. 11, 55 This complication occasionally causes permanent damage to renal function and some patients require dialysis for a long period of time. Furthermore, it can occur several months after colonoscopy examination, thus, continuous ob- 65 and a subsequent study on its effectiveness and safety in humans. 66 In another study, oral sulfate solution was found to be more effective than sulfate-free PEG (administered as a single dose) with similar tolerability. 67 2) Sodium picosulfate/magnesium citrate
In 2012, sodium picosulfate and magnesium citrate were approved by the FDA for split dosing for colonoscopy in adults.
This regimen was compared with PEG solution and sulfate-free PEG solution, and found to be equally or more effective in colon cleansing and to show better tolerability. 68, 69 In one study, sodium picosulfate and magnesium citrate were compared with sodium phosphate and shown to be as effective, but to have better taste and patient tolerability, 70 however, in another study, this regimen was found to be less effective than oral sodium phosphate in terms of bowel cleansing. 71 Several later studies confirmed that this regimen provides effective bowel preparation.
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CONCLUSIONS
Adequate bowel preparation is essential for successful colonoscopy examination, and this largely depends on the type of agent used for bowel preparation. Nevertheless, poor bowel preparation is frequent, resulting in reduced quality of colonoscopy, including reduction of polyp detection rates and increase of complication risk, pain, and medical costs. Thus, selection of the most appropriate agent for each patient is important, and administration methods such as split dosing, patient education including dietary modifications, and walking exercise are also essential for successful examination.
